Sastasundar Ventures

Kolkata, India Founded: 1989 • Age: 37 yrs Listed

Online digital platform for medical services and counselling

Page last updated 19 Oct 2026

About Sastasundar Ventures

Sastasundar Ventures is a publicly listed company based in Kolkata (India) founded in 1989 by B L Mittal. The company has 1,660 employees. Its Indian entity Health X Platform Limited reported revenue of ₹1,378 Cr. Its focus areas include HealthTech, Healthcare Booking Platforms and Diversified. Similar companies include MediBuddy, Practo and API Holdings; 3 of its 3 listed similar companies have raised funding.

Company details

Online digital platform for medical services and counselling. The compny has develeopd online paltrom that allows indivisuals to access diffrent medical services, medicaltions, customised health conditioned products, helath information and more.

Headquarters Kolkata, India
Employees 1,660
Founders B L Mittal
Stage Public
Sectors
Healthcare
Website sastasundarventures.com
Social LinkedIn Facebook Instagram YouTube
Legal Name Sastasundar Ventures Limited

Operational Areas

Healthcare → Digital Health & Telemedicine

Key Metrics

Market Cap
₹871 Cr
HEALTHX · NSE
Share Price
₹272.55
-0.42% today
Revenue
₹1,319 Cr
FY 2025-26 · +13.9% YoY
EBITDA
−₹53.24 Cr
Margin -4.0%
Net Profit
₹1.92 Cr
FY 2025-26 · -97.9% YoY
Employee Count
1,660

Associated legal entities of Sastasundar Ventures

Sastasundar Ventures operates through Health X Platform Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.

Legal entity	Status	Incorporated	Registered in	Revenue (FY 2026)	Employees	Directors	Company page
Health X Platform Limited Listed CIN L65993WB1989PLC047002	Active	06 Jun 1989	Kolkata, West Bengal	₹1,378 Cr	1	8	View details

Apps and channels of Sastasundar Ventures

its YouTube channel SastaSundar, Health & Happiness has 3.87K subscribers and 30 videos.

SastaSundar, Health & Happiness

YouTube 3.87K subscribers 30 videos Howto & Style

Open channel

Videos from Sastasundar Ventures

The most watched videos on Sastasundar Ventures's YouTube channel, SastaSundar, Health & Happiness (3.87K subscribers). Click a video to play it here.

চলে এল মহালয়া, বেজে উঠল আনন্দের সুর | চোখ রাখুন সস্তাসুন্দরের আগমনী প্লেলিস্টে | #mahalaya

1.1M views

🌸Jago Durga | Mahalaya 2025 | আগমনীর সুরে মাতুক বাঙালির মন 🌼| #mahalaya #shortsviral

1.1M views

Don't Risk Your Health with Fake Medicines—Trust SastaSundar for 100% Genuine Meds!

382.8K views

Don't Risk Your Health with Fake Medicines—Trust SastaSundar for 100% Genuine Meds!

127.7K views

More on SastaSundar, Health & Happiness.

Board of directors of Health X Platform Limited (Sastasundar Ventures)

Health X Platform Limited is the primary company behind Sastasundar Ventures. The board of Health X Platform Limited currently have 6 directors; the longest-serving is Banwari Lal Mittal, appointed in 2005. 17 earlier directors have ceased.

Director	Designation	Appointed	Tenure	Entity
Banwari Lal Mittal DIN 00365809	Managing Director	30 May 2005	21 yrs 5 mo	Health X Platform Limited
Ravi Kant Sharma DIN 00364066	Director	30 May 2005	21 yrs 5 mo	Health X Platform Limited
Abha Mittal DIN 00519777	Director	26 Mar 2015	11 yrs 7 mo	Health X Platform Limited
Rupanjana De DIN 01560140	Director	15 Sep 2020	6 yrs 1 mo	Health X Platform Limited
Jayanta Nath Mukhopadhyaya DIN 09015844	Director	22 Jun 2021	5 yrs 4 mo	Health X Platform Limited
Anjana Dikshit DIN 10377490	Director	10 Nov 2023	2 yrs 11 mo	Health X Platform Limited

People of Sastasundar Ventures

1 people are tracked at Sastasundar Ventures (1 in leadership); the tracked headcount is 1,660.

Name	Role	Group
B L Mittal	Founder	Leadership

Premium access

Complete people profiles for Sastasundar Ventures

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

Full employee list
Team structure
Board tenure
Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Sastasundar Ventures

Sastasundar Ventures is a publicly listed company on the NSE with ticker symbol SASTASUNDR in India, operating in the Retail trade sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

IPO date10 May 2010
Listed onBSE: 533259
Listed entitySastasundar Ventures Limited
Exchange sectorRetail trade
ISININE019J01013
Share price₹282.60 (+3.86% on the day) · 2026-04-29
Market capitalisation₹881 Cr
Price to earnings34.6
EPS (diluted, trailing year)₹8.18
Volume (last session)63,781
Analyst consensusNo rating

Financials of Sastasundar Ventures

Exchange-reported figures of Health X Platform Limited, the listed company behind Sastasundar Ventures (NSE: HEALTHX).

Financial Highlights

FY 2025-26 · Consolidated

Revenue

₹1,319 Cr

+13.9% YoY

EBITDA

−₹53.24 Cr

+74.8% YoY

Profit After Tax

₹1.92 Cr

-97.9% YoY

Net Worth

₹641 Cr

-4.3% YoY

Total Assets

₹791 Cr

-8.6% YoY

Total Debt

₹25.65 Cr

+2688.0% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

Metrics	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Income statement
Revenue	1,319	1,159	1,432	1,060	1,798	551	388
Revenue growth	+13.9%	-19.1%	+35.1%	-41.0%	+226.5%	+42.0%	-
EBITDA	(53.24)	(211)	(24.38)	(115)	1,114	(10.26)	(52.20)
EBITDA margin	-4.0%	-18.2%	-1.7%	-10.9%	+62.0%	-1.9%	-13.5%
Profit before tax	(2.35)	(204)	(30.51)	(122)	1,109	(16.36)	(57.57)
Net profit	1.92	90.97	8.82	(65.43)	(287)	(10.42)	(39.05)
Net profit margin	+0.2%	+7.9%	+0.6%	-6.2%	-16.0%	-1.9%	-10.1%
EPS (₹)	0.37	(28.66)	2.79	(22.70)	197.04	(3.27)	(12.20)
Balance sheet
Total assets	791	865	1,003	1,003	1,096	242	254
Net worth	641	670	762	753	826	200	210
Total debt	25.65	0.92	3.88	9.33	1.85	12.50	7.85
Cash & bank	30.22	12.44	46.66	195	212	12.80	18.27
Net working capital	137	162	276	465	440	79.83	75.75
Cash flow
Cash from operations	(73.83)	(17.31)	35.86	(112)	(207)	(30.51)	(69.24)
Cash from investing	171	(1.13)	(33.93)	133	220	21.37	(22.13)
Cash from financing	(79.59)	(0.44)	(2.35)	(1.83)	(11.42)	3.73	103

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Revenue	447	374	346	301	298	286	281	274
Revenue growth (YoY)	+49.7%	+30.8%	+22.9%	+10.2%	+10.4%	-	-	-
Other income	12.83	13.76	13.62	5.51	25.38	21.91	(11.83)	22.29
EBITDA	(8.37)	(26.16)	(10.36)	(22.79)	6.06	(25.19)	(25.93)	(194)
EBITDA margin	-1.9%	-7.0%	-3.0%	-7.6%	+2.0%	-8.8%	-9.2%	-71.1%
Depreciation	1.89	1.94	2.17	1.33	1.17	1.34	1.43	1.45
Interest	0.59	0.49	0.17	0.04	0.09	0.01	0.05	0.06
Profit before tax	1.98	(14.83)	0.92	(18.65)	30.18	(4.63)	(39.24)	(174)
Tax	(0.01)	(1.85)	0.55	(3.20)	3.59	(22.20)	0.78	(22.87)
Net profit	1.99	(12.98)	0.37	(15.45)	26.59	17.57	(40.02)	(151)
EPS (₹)	0.80	(3.51)	0.35	(3.99)	7.52	4.30	(8.47)	(34.40)

Metrics	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Income statement
Revenue	0.38	0.44	0.45	0.25	0.19	0.28	0.31
Revenue growth	-13.6%	-2.2%	+80.0%	+31.6%	-32.1%	-9.7%	-
EBITDA	(1.18)	(1.35)	(1.47)	(1.16)	(0.86)	(0.64)	(1.03)
EBITDA margin	-310.5%	-306.8%	-326.7%	-464.0%	-452.6%	-228.6%	-332.3%
Profit before tax	(0.96)	(0.72)	(0.88)	0.65	(0.35)	(0.16)	0.63
Net profit	(0.96)	(0.73)	(0.88)	(0.60)	(0.41)	(0.16)	(0.66)
Net profit margin	-252.6%	-165.9%	-195.6%	-240.0%	-215.8%	-57.1%	-212.9%
EPS (₹)	(0.30)	(0.22)	(0.28)	0.20	(0.12)	(0.04)	0.20
Balance sheet
Total assets	271	272	273	273	273	273	273
Net worth	271	272	273	273	273	273	273
Total debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash & bank	0.08	0.05	0.11	0.22	0.20	0.18	0.22
Net working capital	0.73	0.93	5.64	5.69	4.71	0.58	0.44
Cash flow
Cash from operations	0.04	(5.51)	(1.21)	(0.63)	(0.52)	(0.51)	(0.83)
Cash from investing	(0.01)	5.45	1.09	0.64	0.54	0.47	0.97
Cash from financing	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Revenue	0.08	0.09	0.09	0.10	0.10	0.10	0.11	0.11
Revenue growth (YoY)	-20.0%	-10.0%	-18.2%	-9.1%	+25.0%	-	-	-
Other income	0.01	0.10	0.01	0.01	0.26	0.20	0.19	0.19
Total expenses	0.59	0.32	0.49	0.37	0.38	0.34	0.38	0.59
EBITDA	(0.51)	(0.23)	(0.40)	(0.27)	(0.28)	(0.24)	(0.27)	(0.48)
EBITDA margin	-637.5%	-255.6%	-444.4%	-270.0%	-280.0%	-240.0%	-245.5%	-436.4%
Depreciation	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02
Interest	0.00	0.00	0.00	0.00	0.06	0.00	0.00	0.00
Profit before tax	(0.52)	(0.15)	(0.41)	(0.28)	(0.10)	(0.06)	(0.10)	(0.31)
Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 08 Nov 2026

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Revenue	447	374	346	301	298	286	281	274
Revenue growth (YoY)	+49.7%	+30.8%	+22.9%	+10.2%	+10.4%	-	-	-
Other income	12.83	13.76	13.62	5.51	25.38	21.91	(11.83)	22.29
EBITDA	(8.37)	(26.16)	(10.36)	(22.79)	6.06	(25.19)	(25.93)	(194)
EBITDA margin	-1.9%	-7.0%	-3.0%	-7.6%	+2.0%	-8.8%	-9.2%	-71.1%
Depreciation	1.89	1.94	2.17	1.33	1.17	1.34	1.43	1.45
Interest	0.59	0.49	0.17	0.04	0.09	0.01	0.05	0.06
Profit before tax	1.98	(14.83)	0.92	(18.65)	30.18	(4.63)	(39.24)	(174)
Tax	(0.01)	(1.85)	0.55	(3.20)	3.59	(22.20)	0.78	(22.87)
Net profit	1.99	(12.98)	0.37	(15.45)	26.59	17.57	(40.02)	(151)
EPS (₹)	0.80	(3.51)	0.35	(3.99)	7.52	4.30	(8.47)	(34.40)

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Revenue	1,319	1,159	1,432	1,060	1,798	551	388
Revenue growth	+13.9%	-19.1%	+35.1%	-41.0%	+226.5%	+42.0%	-
Other income	58.27	13.46	4.08	3.07	2.82	0.98	0.99
Total expenses	1,373	1,370	1,456	1,176	684	561	440
Employee cost	0.00	49.79	49.02	45.35	43.94	29.13	28.45
EBITDA	(53.24)	(211)	(24.38)	(115)	1,114	(10.26)	(52.20)
EBITDA margin	-4.0%	-18.2%	-1.7%	-10.9%	+62.0%	-1.9%	-13.5%
Depreciation	6.60	5.83	9.14	8.20	4.16	4.47	4.90
Interest	0.78	0.29	1.07	1.94	3.34	2.61	1.46
Profit before tax	(2.35)	(204)	(30.51)	(122)	1,109	(16.36)	(57.57)
Tax	(0.91)	(70.12)	(36.36)	(22.78)	244	0.72	(5.43)
Net profit	1.92	90.97	8.82	(65.43)	(287)	(10.42)	(39.05)
Net profit margin	+0.2%	+7.9%	+0.6%	-6.2%	-16.0%	-1.9%	-10.1%
EPS (₹)	0.37	(28.66)	2.79	(22.70)	197.04	(3.27)	(12.20)

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Equity & liabilities
Share capital	31.81	31.81	31.81	31.81	31.81	31.81	31.81
Reserves & surplus	609	638	726	717	790	163	173
Shareholders' funds (net worth)	641	670	762	753	826	200	210
Minority interest	124	195	237	240	268	29.48	36.10
Secured loans	22.09	0.00	0.00	0.00	0.00	9.79	5.01
Unsecured loans	3.56	0.92	3.88	9.33	1.85	2.71	2.84
Total debt	25.65	0.92	3.88	9.33	1.85	12.50	7.85
Total liabilities	791	865	1,003	1,003	1,096	242	254
Assets
Gross block	155	139	143	132	111	126	124
Net block	117	102	110	107	93.42	110	114
Capital work in progress	1.20	10.24	0.35	0.99	0.42	0.08	0.01
Investments	519	575	676	513	666	43.42	55.77
Inventories	145	110	116	181	114	77.18	77.09
Sundry debtors	7.66	9.98	34.79	35.08	21.20	13.56	14.96
Cash & bank balances	30.22	12.44	46.66	195	212	12.80	18.27
Loans & advances	93.56	134	157	164	161	26.93	26.86
Total current assets	276	267	354	575	508	130	137
Total current liabilities	139	105	78.54	110	68.04	50.64	61.43
Net working capital	137	162	276	465	440	79.83	75.75
Total assets	791	865	1,003	1,003	1,096	242	254

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Opening cash	12.42	31.31	31.72	13.01	12.04	17.45	6.31
Net cash from operating activities	(73.83)	(17.31)	35.86	(112)	(207)	(30.51)	(69.24)
Net cash from investing activities	171	(1.13)	(33.93)	133	220	21.37	(22.13)
Net cash from financing activities	(79.59)	(0.44)	(2.35)	(1.83)	(11.42)	3.73	103
Net change in cash	17.77	(18.89)	(0.41)	18.72	0.96	(5.41)	11.14
Closing cash	30.22	12.44	46.66	195	212	12.80	18.27

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Growth
Sales growth	+13.9%	-19.1%	+35.1%	-41.0%	+226.5%	+42.0%	-
EBITDA growth	+74.8%	-765.5%	+78.8%	-110.3%	-	+80.3%	-
PBT growth	+98.9%	-567.5%	+75.1%	-	+9998.0%	+71.6%	-37.9%
Net income growth	-97.9%	+931.4%	+113.5%	+77.2%	-2658.6%	+73.3%	-
Revenue CAGR (3Y)	+7.6%	-13.6%	+37.5%	+39.8%	+100.9%	+50.4%	+42.2%
EBITDA CAGR (3Y)	-22.7%	-	+33.4%	+30.2%	-	-6.9%	+37.6%
Profitability & leverage
Net income margin	-0.1%	-11.5%	+0.4%	-9.4%	+48.1%	-3.1%	-13.4%
Return on capital employed	-	-1.7%	-3.9%	-15.1%	-8.6%	0.0%	0.0%
Return on net worth	-	+6.8%	+0.8%	-12.6%	-9.6%	0.0%	0.0%
Debt / equity	-	0.00	0.01	0.01	0.01	0.05	0.03
Long-term debt / equity	-	0.00	0.01	0.01	0.00	0.01	0.01
Interest cover	-1.30	-0.13	-3.19	-1.57	0.30	-17.72	-2.56
Efficiency & per share
Fixed asset turnover	-	8.33	10.46	8.75	15.20	4.41	3.15
Inventory turnover	-	10.37	9.68	7.23	18.88	7.15	7.09
Debtors turnover	-	52.36	41.11	37.79	103.60	38.68	34.05
EPS (₹)	0.37	(28.66)	2.79	(22.70)	197.04	(3.27)	(12.20)
Dividend per share (₹)	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Book value per share (₹)	0.00	210.58	238.09	235.27	258.25	61.27	64.48

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Revenue	0.08	0.09	0.09	0.10	0.10	0.10	0.11	0.11
Revenue growth (YoY)	-20.0%	-10.0%	-18.2%	-9.1%	+25.0%	-	-	-
Other income	0.01	0.10	0.01	0.01	0.26	0.20	0.19	0.19
Total expenses	0.59	0.32	0.49	0.37	0.38	0.34	0.38	0.59
EBITDA	(0.51)	(0.23)	(0.40)	(0.27)	(0.28)	(0.24)	(0.27)	(0.48)
EBITDA margin	-637.5%	-255.6%	-444.4%	-270.0%	-280.0%	-240.0%	-245.5%	-436.4%
Depreciation	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02
Interest	0.00	0.00	0.00	0.00	0.06	0.00	0.00	0.00
Profit before tax	(0.52)	(0.15)	(0.41)	(0.28)	(0.10)	(0.06)	(0.10)	(0.31)
Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Revenue	0.38	0.44	0.45	0.25	0.19	0.28	0.31
Revenue growth	-13.6%	-2.2%	+80.0%	+31.6%	-32.1%	-9.7%	-
Other income	0.38	0.76	0.73	2.00	0.72	0.68	1.87
Total expenses	1.56	1.79	1.92	1.41	1.05	0.92	1.34
Employee cost	0.00	0.47	0.51	0.43	0.35	0.33	0.45
EBITDA	(1.18)	(1.35)	(1.47)	(1.16)	(0.86)	(0.64)	(1.03)
EBITDA margin	-310.5%	-306.8%	-326.7%	-464.0%	-452.6%	-228.6%	-332.3%
Depreciation	0.10	0.10	0.10	0.16	0.18	0.17	0.18
Interest	0.06	0.03	0.04	0.03	0.03	0.03	0.03
Profit before tax	(0.96)	(0.72)	(0.88)	0.65	(0.35)	(0.16)	0.63
Tax	0.00	0.00	0.00	0.00	0.05	0.00	0.00
Net profit	(0.96)	(0.73)	(0.88)	(0.60)	(0.41)	(0.16)	(0.66)
Net profit margin	-252.6%	-165.9%	-195.6%	-240.0%	-215.8%	-57.1%	-212.9%
EPS (₹)	(0.30)	(0.22)	(0.28)	0.20	(0.12)	(0.04)	0.20

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Equity & liabilities
Share capital	31.81	31.81	31.81	31.81	31.81	31.81	31.81
Reserves & surplus	239	240	241	242	241	241	242
Shareholders' funds (net worth)	271	272	273	273	273	273	273
Secured loans	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured loans	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total liabilities	271	272	273	273	273	273	273
Assets
Gross block	2.64	2.75	2.75	2.74	3.83	3.77	3.77
Net block	1.76	1.93	2.02	2.12	3.12	3.24	3.41
Capital work in progress	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	265	265	265	266	265	269	270
Inventories	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Sundry debtors	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash & bank balances	0.08	0.05	0.11	0.22	0.20	0.18	0.22
Loans & advances	0.81	1.23	5.92	5.90	4.81	0.67	0.78
Total current assets	0.89	1.28	6.03	6.12	5.01	0.85	1.00
Total current liabilities	0.16	0.35	0.39	0.43	0.30	0.27	0.56
Net working capital	0.73	0.93	5.64	5.69	4.71	0.58	0.44
Total assets	271	272	273	273	273	273	273

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Opening cash	0.03	0.08	0.20	0.18	0.16	0.20	0.06
Net cash from operating activities	0.04	(5.51)	(1.21)	(0.63)	(0.52)	(0.51)	(0.83)
Net cash from investing activities	(0.01)	5.45	1.09	0.64	0.54	0.47	0.97
Net cash from financing activities	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net change in cash	0.03	(0.06)	(0.11)	0.02	0.02	(0.04)	0.14
Closing cash	0.08	0.05	0.11	0.22	0.20	0.18	0.22

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Growth
Sales growth	-13.6%	-2.2%	+80.0%	+31.6%	-32.1%	-9.7%	-
EBITDA growth	+12.6%	+8.2%	-26.7%	-34.9%	-34.4%	+37.9%	-
PBT growth	-33.3%	+18.2%	-	+9998.0%	-118.8%	-	+10.5%
Net income growth	-31.5%	+17.1%	-46.7%	-46.3%	-156.3%	+75.8%	-
Revenue CAGR (3Y)	+15.0%	+32.3%	+17.1%	-6.9%	-57.5%	-41.9%	-31.9%
EBITDA CAGR (3Y)	+0.6%	+16.2%	+31.9%	+4.0%	-	+10.1%	-21.5%
Profitability & leverage
Net income margin	-252.6%	-163.6%	-195.6%	+260.0%	-210.5%	-57.1%	+203.2%
Return on capital employed	-	-0.3%	-0.3%	-0.2%	-0.1%	-0.0%	-0.2%
Return on net worth	-	-0.3%	-0.3%	-0.2%	-0.1%	-0.1%	-0.2%
Debt / equity	-	0.00	0.00	0.00	0.00	0.00	0.00
Long-term debt / equity	-	0.00	0.00	0.00	0.00	0.00	0.00
Interest cover	-4.69	-2.07	-2.55	-2.27	-2.88	-3.70	-2.48
Efficiency & per share
Fixed asset turnover	-	0.44	0.43	0.68	0.24	0.25	0.55
Inventory turnover	-	0.00	0.00	0.00	0.00	0.00	0.00
Debtors turnover	-	0.00	0.00	0.00	0.00	0.00	0.00
EPS (₹)	(0.30)	(0.22)	(0.28)	0.20	(0.12)	(0.04)	0.20
Dividend per share (₹)	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Book value per share (₹)	0.00	85.45	85.67	85.95	85.76	85.90	85.95

Similar companies to Sastasundar Ventures

Sastasundar Ventures has 3 listed similar companies in our database, 3 of them funded. They include MediBuddy, Practo and API Holdings.

Company Name	Domain	Founded	HQ Location	Total funding	Employees	Description
MediBuddy	medibuddy.in	2013	Bengaluru, India	$193.12M	1,192	Online platform offering multiple healthcare services
Practo	practo.com	2008	Bengaluru, India	$227.88M		Doctor appointments are booked and healthcare professionals are consulted online.
API Holdings	apiholdings.in	2012	Mumbai, India	$1.19B	221	Digital healthcare tools are offered for pharmacies and clinics management.

Premium access

Detailed similar companies of Sastasundar Ventures

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

Full competitor set
Operating metrics
Benchmarks
Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Sastasundar Ventures

Websites that share an audience with Sastasundar Ventures (sastasundarventures.com).

Similar websites

Websites whose visitors overlap most with Sastasundar Ventures. Affinity shows how closely the audiences match.

Website	Domain	Audience affinity	Monthly visits	Global rank	Profile
SastaSundar	sastasundar.com	100%	389.2K	#79,860	View details

Top companies in Digital Health & Telemedicine

3 companies that operate in the same segment as Sastasundar Ventures (Digital Health & Telemedicine) in India, ranked by their profile score on The Company Check.

Company	Description	Founded	Location	Total funding	Revenue	Employees
Tata 1mg	Provider of an online pharmacy with doctor listing and teleconsultation services	2015	Delhi, Delhi, India	USD 199.65 M	USD 328.97 M	5,212
MediBuddy	Online platform offering multiple healthcare services	2013	Bengaluru, Karnataka, India	USD 199.22 M	USD 62.4 M	52
SastaSundar	An online marketplace for healthcare products is operated.	2011	Kolkata, West Bengal, India	USD 38.26 M

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.

Included in your Premium account

✓
Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
✓
Full access to every database India & global coverage, advanced filters and rich profile details
✓
Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Sastasundar Ventures

When was Sastasundar Ventures founded?

Sastasundar Ventures was founded in 1989.

Where is Sastasundar Ventures located?

Sastasundar Ventures is headquartered in Kolkata, India. It is registered at Kolkata, West Bengal, India.

How many employees does Sastasundar Ventures have?

Sastasundar Ventures has 1,660 employees.

What is the annual revenue of Sastasundar Ventures?

The primary company behind Sastasundar Ventures, Health X Platform Limited, reported revenue of ₹1,378 Cr for FY 2026, up 14% year on year.

What does Sastasundar Ventures do?

Which companies are similar to Sastasundar Ventures?

Sastasundar Ventures's top competitors include MediBuddy, Practo and API Holdings.

Is Sastasundar Ventures publicly traded?

Yes, Sastasundar Ventures is publicly traded on NSE under the ticker symbol SASTASUNDR.

Which legal entities are associated with Sastasundar Ventures?

Sastasundar Ventures operates through Health X Platform Limited.

Who are the directors of Sastasundar Ventures?

The legal entities of Sastasundar Ventures currently have 8 directors, including Banwari Lal Mittal, Jayanta Nath Mukhopadhyaya, Ravi Kant Sharma and others.

Sastasundar Ventures

About Sastasundar Ventures

Company details

Operational Areas of Sastasundar Ventures

Associated legal entities of Sastasundar Ventures

Apps and channels of Sastasundar Ventures

Videos from Sastasundar Ventures

Board of directors of Health X Platform Limited (Sastasundar Ventures)

People of Sastasundar Ventures

Complete people profiles for Sastasundar Ventures

IPO & Listings of Sastasundar Ventures

Financials of Sastasundar Ventures

Financial Highlights

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

Financial Statements

Similar companies to Sastasundar Ventures

Detailed similar companies of Sastasundar Ventures

Web traffic of Sastasundar Ventures

Top companies in Digital Health & Telemedicine

Related news about Sastasundar Ventures

Complete news archive for Sastasundar Ventures

Frequently Asked Questions about Sastasundar Ventures

About Sastasundar Ventures

Company details

Operational Areas of Sastasundar Ventures

Associated legal entities of Sastasundar Ventures

Apps and channels of Sastasundar Ventures

Videos from Sastasundar Ventures

Board of directors of Health X Platform Limited (Sastasundar Ventures)

People of Sastasundar Ventures

Complete people profiles for Sastasundar Ventures

IPO & Listings of Sastasundar Ventures

Financials of Sastasundar Ventures

Financial Highlights

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr Consolidated Standalone AnnualQuarterly

Financial Statements

Similar companies to Sastasundar Ventures

Detailed similar companies of Sastasundar Ventures

Web traffic of Sastasundar Ventures

Top companies in Digital Health & Telemedicine

Related news about Sastasundar Ventures

Complete news archive for Sastasundar Ventures

Frequently Asked Questions about Sastasundar Ventures

Financial summary ₹ Cr